Stocks in play: ProMIS Neurosciences, Inc.
Has filed, and obtained a receipt for, a final short form base shelf prospectus with the securities regulators in each of the provinces and territories of Canada, except Quebec. ProMIS Neurosciences, Inc. shares T.PMN are trading down $0.005 at $0.21.
Read: The Small Exploration Company That Shocked The Oil Industry